Champions Oncology Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Champions Oncology stock has a target of 12, which predicts a 74.80% increase from the current stock price of 6.87.

Price Target: $12.00 (+74.80%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$12	$12	$12	$12
Change	+74.80%	+74.80%	+74.80%	+74.80%

* Price targets were last updated on Mar 12, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for Champions Oncology is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matt Hewitt Craig-Hallum	Craig-Hallum	Strong Buy Maintains $8 → $12	Strong Buy	Maintains	$8 → $12	+74.80%	Mar 12, 2025
Matt Hewitt Craig-Hallum	Craig-Hallum	Strong Buy Maintains $6 → $8	Strong Buy	Maintains	$6 → $8	+16.53%	Dec 12, 2024
Matt Hewitt Craig-Hallum	Craig-Hallum	Hold → Strong Buy Upgrades $6	Hold → Strong Buy	Upgrades	$6	-12.60%	Sep 12, 2024
Matt Hewitt Craig-Hallum	Craig-Hallum	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Mar 13, 2024
Scott Henry Roth MKM	Roth MKM	Strong Buy Maintains $9 → $7.5	Strong Buy	Maintains	$9 → $7.5	+9.25%	Sep 22, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

62.24M

from 56.94M

9.30%

from 56.94M

Revenue Next Year

81.64M

from 62.24M

31.17%

from 62.24M

EPS This Year

0.22

from 0.33

-32.00%

from 0.33

EPS Next Year

n/a

from 0.22

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Apr 30, 2021	Apr 30, 2022	Apr 30, 2023	Apr 30, 2024	Apr 30, 2025	Apr 30, 2026	Apr 30, 2027	Apr 30, 2028
Revenue	41.04M	49.11M	53.87M	50.16M	56.94M	62.24M	81.64M	95.93M
Revenue Growth	27.76%	19.66%	9.70%	-6.90%	13.54%	9.30%	31.17%	17.50%
EPS	0.02	0.04	-0.39	-0.54	0.33	0.22	-	-
EPS Growth	-	100.01%	-	-	-	-32.00%	-	-
Forward PE	-	-	-	-	-	30.59	-	-
No. Analysts	-	-	-	-	-	3	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028
High	64.1M	84.0M	98.7M
Avg	62.2M	81.6M	95.9M
Low	59.8M	78.4M	92.2M

Revenue Growth

Revenue Growth	2026	2027	2028
High	12.5%	35.0%	21.0%
Avg	9.3%	31.2%	17.5%
Low	5.0%	26.0%	12.9%

EPS Forecast

EPS	2026
High	0.23
Avg	0.22
Low	0.22

EPS Growth

EPS Growth	2026
High	-30.0%
Avg	-32.0%
Low	-34.7%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.